Onsior® (robenacoxib) for Cats
Help get them from hospital to home comfortably
With demonstrated efficacy for use up to a maximum of 3 days, Onsior™ should be your NSAID of choice for spay/neuter pain relief.
Onsior™ is an excellent option because it:
- is ideal for spays and neuters
- is rapidly absorbed and persists at the site of inflammation3
*clinical relevance unknown.
Features of Onsior
Onsior™ tablets are the only feline NSAID approved for 3 days of post-operative control of pain and inflammation.1
It has a fast onset of action and persists where it is needed most.1
It has a strong safety profile.1 Onsior™ even received the “Easy to Give” Award. Onsior™ tablet and injectable can be used interchangeably.1
In an in vitro whole blood assay in cats, Onsior™ demonstrated selective COX-2 inhibition.1
Onsior™ is quickly absorbed into the blood stream upon injection or oral administration and is rapidly eliminated from the blood.1
Onsior™ is a highly protein-bound NSAID. It persists longer at the site of inflammation than in the blood because inflammatory exudate is rich in plasma proteins, thereby providing sustained drug levels at the site of action.2,3
Our Product
Onsior™ 20ml
INDICATION
ONSIOR® tablets for Cats are indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration, in cats ≥ 5.5 lbs and ≥ 4 months of age; for up to a maximum of 3 days.
ONSIOR® injection is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 4 months of age; for up to a maximum of 3 days.
IMPORTANT SAFETY INFORMATION
Do not use in cats that have hypersensitivity to robenacoxib or known intolerance to NSAIDs. Do not administer Onsior® tablets or injection in conjunction with any other NSAID or corticosteroid. Do not use for more than 3 days. A thorough history and physical exam including appropriate testing should be conducted before initiation of a NSAID therapy. Owners should be advised to observe for signs of potential drug toxicity. Stop administration of ONSIOR® if appetite decreases or if the cat becomes lethargic. The use of ONSIOR® has not been evaluated in cats used for breeding, or in pregnant or lactating cats or in cats with cardiac disease. As a class, cyclo-oxygenase inhibitory NSAIDS may be associated with gastrointestinal, renal, and hepatic toxicity. For full prescribing information see label links below.
DISCLAIMER
Onsior™ is a trademark of Elanco or its affiliates.
REFERENCE
- Onsior™ Tablet for Cats product insert
- Pelligand LK, Toutain, JN, Elliot PL, Lees J. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation. J Vet Pharmacol Therap. 2011;35:19-32.
- Silber HE, Burgener C, Letellier IM, et al. Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis. Pharm Res. 2010;27(12):2633-45.
